
Interpace Biosciences IDXG
$ 1.8
0.0%
Quarterly report 2026-Q1
added 05-12-2026
Interpace Biosciences EV - Enterprise Value 2011-2026 | IDXG
Annual EV - Enterprise Value Interpace Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.3 M | 19.7 M | 24.6 M | 32.3 M | 53.9 M | 41.7 M | 82.3 M | 34.8 M | 15.9 M | 42.2 M | 50.5 M | 95.9 M | 77.5 M | 102 M | 85.3 M | -7.84 M | -72.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 102 M | -72.5 M | 40.9 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
463 M | $ 20.03 | 4.32 % | $ 581 M | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 16.41 | 2.88 % | $ 496 M | ||
|
Guardant Health
GH
|
15.2 B | $ 114.97 | 17.09 % | $ 14.4 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 115.09 | 1.36 % | $ 9.49 B | ||
|
Agilent Technologies
A
|
45.8 B | $ 113.78 | 2.96 % | $ 34.6 B | ||
|
Illumina
ILMN
|
15.3 B | $ 141.92 | 0.17 % | $ 22.6 B | ||
|
Celcuity
CELC
|
5.57 B | $ 140.34 | 7.16 % | $ 6.56 B | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 2.39 | 21.32 % | $ 3.18 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 21.15 | 3.02 % | $ 1.13 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 96.09 | 3.44 % | $ 6.49 B | ||
|
Medpace Holdings
MEDP
|
14 B | $ 421.87 | 0.47 % | $ 12.2 B | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 082.67 | 3.04 % | $ 22.3 B | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
National Research Corporation
NRC
|
432 M | $ 19.26 | 2.72 % | $ 431 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Natera
NTRA
|
5.53 B | $ 204.92 | 4.53 % | $ 20.2 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Personalis
PSNL
|
380 M | $ 7.95 | 12.93 % | $ 709 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 156.03 | 2.36 % | $ 7.73 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.9 | 6.08 % | $ 1.14 B | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 3.81 | 7.32 % | $ 353 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 26.74 | 2.65 % | $ 25.4 B | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 451.79 | 0.89 % | $ 170 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 5.71 | 3.07 % | $ 238 M | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 53.66 | 8.4 % | $ 3.21 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.35 | -1.26 % | $ 5.4 M | ||
|
Trinity Biotech plc
TRIB
|
327 M | $ 0.6 | 6.95 % | $ 216 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 257.42 | 1.47 % | $ 21.4 B | ||
|
Waters Corporation
WAT
|
21.6 B | $ 341.32 | 2.42 % | $ 20.3 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 8.83 | 5.75 % | $ 1.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 193.75 | 1.92 % | $ 21.5 B |